These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1848470)

  • 1. DNA ploidy in the primary tumor from patients with nonseminomatous testicular germ cell tumors clinical stage I.
    Fosså SD; Nesland JM; Waehre H; Amellem O; Pettersen EO
    Cancer; 1991 Apr; 67(7):1874-7. PubMed ID: 1848470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of aneuploid stemlines in testicular nonseminomatous germ cell tumors.
    de Graaff WE; Sleijfer DT; de Jong B; Dam A; Schraffordt Koops H; Oosterhuis JW
    Cancer; 1993 Aug; 72(4):1300-4. PubMed ID: 8393372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric DNA ploidy pattern for predicting metastasis of clinical stage I nonseminomatous germ cell testicular tumors.
    Austenfeld MS; Bilhartz DL; Nativ O; Farrow GM; Lieber MM
    Urology; 1993 Apr; 41(4):379-83. PubMed ID: 8385834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometric and quantitative histological parameters to predict occult disease in clinical stage I nonseminomatous testicular germ cell tumors.
    Moul JW; Foley JP; Hitchcock CL; McCarthy WF; Sesterhenn IA; Becker RL; Griffin JL
    J Urol; 1993 Sep; 150(3):879-83. PubMed ID: 8393944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies on nuclear DNA content in testicular germ cell tumors using flow cytometry].
    Kashiwagi A
    Hokkaido Igaku Zasshi; 1992 Nov; 67(6):801-14. PubMed ID: 1336479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [DNA ploidy of testicular germ cell tumors in childhood; difference from adult testicular tumors].
    Kashiwagi A; Nagamori S; Toyota K; Maeno K; Koyanagi T
    Nihon Hinyokika Gakkai Zasshi; 1993 Sep; 84(9):1655-9. PubMed ID: 8411821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ploidy of testicular carcinoma in situ.
    de Graaff WE; Oosterhuis JW; de Jong B; Dam A; van Putten WL; Castedo SM; Sleijfer DT; Schraffordt Koops H
    Lab Invest; 1992 Feb; 66(2):166-8. PubMed ID: 1310514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative DNA measurement by flow cytometry and image analysis of human nonseminomatous germ cell testicular tumors.
    de Riese W; Walker EB; de Riese C; Ulbright TM; Crabtree WN; Messemer J; Jones JA; Hinkel A; Foster RS; Donohue JP
    Urol Res; 1994; 22(4):213-20. PubMed ID: 7871632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. alpha-Catenin expression pattern and DNA image-analysis cytometry have no additional value over primary histology in clinical stage I nonseminomatous testicular cancer.
    Spermon JR; De Wilde PC; Hanselaar AG; Schaafsma HE; Ruijter TE; Witjes JA; Van Moorselaar RJ
    BJU Int; 2002 Feb; 89(3):278-84. PubMed ID: 11856111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive parameters of biologic behavior of early stage nonseminomatous testicular germ cell tumors.
    de Riese WT; Albers P; Walker EB; Ulbright TM; Crabtree WN; Reister T; Foster RS; Donohue JP
    Cancer; 1994 Aug; 74(4):1335-41. PubMed ID: 8055457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ploidy of malignant mediastinal germ-cell tumors.
    Oosterhuis JW; Rammeloo RH; Cornelisse CJ; De Jong B; Dam A; Sleijfer DT
    Hum Pathol; 1990 Jul; 21(7):729-32. PubMed ID: 2163363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New parameters for prediction of pathological stage in clinical stage I non-seminomatous testicular tumors].
    Albers P; Ulbright TM; Albers J; Miller GA; Foster RS; Donohue JP
    Urologe A; 1995 Jul; 34(4):316-23. PubMed ID: 7676541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testicular seminomas are aneuploid tumors.
    Hittmair A; Rogatsch H; Feichtinger H; Hobisch A; Mikuz G
    Lab Invest; 1995 Jan; 72(1):70-4. PubMed ID: 7837793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ploidy of primary germ cell tumors of the testis. Pathogenetic and clinical relevance.
    Oosterhuis JW; Castedo SM; de Jong B; Cornelisse CJ; Dam A; Sleijfer DT; Schraffordt Koops H
    Lab Invest; 1989 Jan; 60(1):14-21. PubMed ID: 2536126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High levels of DNA index heterogeneity in advanced breast carcinomas. Evidence for DNA ploidy differences between lymphatic and hematogenous metastases.
    Bonsing BA; Beerman H; Kuipers-Dijkshoorn N; Fleuren GJ; Cornelisse CJ
    Cancer; 1993 Jan; 71(2):382-91. PubMed ID: 8422632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor proliferative activity is predictive of pathological stage in clinical stage A nonseminomatous testicular germ cell tumors.
    Albers P; Ulbright TM; Albers J; Miller GA; Orazi A; Crabtree WN; Baniel J; Reister T; Sidner RA; Foster RS; Donohue JP
    J Urol; 1996 Feb; 155(2):579-86. PubMed ID: 8558664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Flow cytometric analysis of DNA content in adult testicular germ cell tumors].
    Kashiwagi A; Nagamori S; Nonomura K; Toyota K; Koyanagi T; Nojima T; Inoue K
    Nihon Hinyokika Gakkai Zasshi; 1992 Jul; 83(7):1062-70. PubMed ID: 1324379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA ploidy in testicular germ cell neoplasms. Histogenetic and clinical implications.
    el-Naggar AK; Ro JY; McLemore D; Ayala AG; Batsakis JG
    Am J Surg Pathol; 1992 Jun; 16(6):611-8. PubMed ID: 1318004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Flow cytometric DNA analysis of pediatric solid tumor].
    Taniguchi K; Hamazaki M
    Rinsho Byori; 1990 Sep; 38(9):1059-66. PubMed ID: 2172599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Flow cytometric analysis of DNA ploidy using paraffin-embedded germ cell tumors].
    Yoshihiro S; Yamamoto M; Shimabukuro T; Matsuyama H; Yamamoto N; Sakatoku J
    Hinyokika Kiyo; 1991 Jun; 37(6):601-5. PubMed ID: 1892008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.